Prognostic impact of prior local therapy in castration-resistant prostate cancer
ConclusionsThis study robustly indicated that prior local treatment was prognostic for overall survival among patients with CRPC. This finding is useful to predict patient prognosis in CRPC.
Source: Japanese Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Docetaxel | Japan Health | Prostate Cancer | Study | Taxotere